AIDS United
Drew Gibson serves as the Director of Advocacy at AIDS United since August 2016, with a focus on increasing access to syringe services programs and harm reduction efforts across the United States. Previously, positions held include Senior Policy Manager and Policy Manager for HIV & Drug User Health, where responsibilities encompassed comprehensive policy analysis, collaboration with various coalitions, and production of advocacy-related written content. Drew has experience as a Policy Associate creating content for the AIDS United blog, and as a Freelance Writer for The Body, contributing feature and opinion pieces on HIV/AIDS. Other roles include providing policy and communications consulting for the Shoulder to Shoulder Campaign and social media direction for Virally Suppressed. Drew's previous experience also involves case management for individuals living with HIV/AIDS, research assistance at the Office of National Drug Control Policy, and case management internships. Academic qualifications include a Master of Social Work with a concentration in Management & Community Organizing from the University of Maryland Baltimore and a Bachelor of Arts in English from Xavier University.
AIDS United
AIDS United is singularly focused on ending the HIV epidemic in the United States. During our almost 30-year history, we have changed and grown the funding landscape for HIV and transformed the policy environment. To date we have directly funded more than $98 million to local communities and have leveraged more than $115 million in additional support for programs that include access to care for people living with HIV, capacity building for community-based organizations, HIV prevention, advocacy, syringe access, and more. Through our Public Policy Committee, we’ve built the largest and strongest coalition of HIV-focused organizations working at the community level. Our coalition works together every day to ensure national and local policies reflect local realities and support an effective response to the end of AIDS.